Search the Newsreel

Cogent Communications (NASDAQ:CCOI) Releases Earnings Results, Beats Expectations By $2.38 EPS

Cogent Communications (NASDAQ:CCOI) reported quarterly earnings of $1.38 per share, significantly surpassing the consensus estimate of a $1.00 loss, though revenue of $235.6 million fell short of expectations and declined 4.4% year-over-year. The company improved profitability and reduced debt by selling data centers and …

Cogent Communications Holdings, (CCOI) Stock forecasts

Cognyte Software Ltd (CGNT) Stock News Today

This article provides an overview of Cognyte Software Ltd (CGNT) stock news on TradingKey. It displays current stock performance, market capitalization, and indicates that more news, earnings reports, and analyst ratings are expected soon. The page serves as a hub for financial information regarding …

Cognition Therapeutics Inc Q2 2026: Net loss $(3.9M), EPS $(0.04) — 10-Q Summary

Cognition Therapeutics Inc. reported a consolidated net loss of $3.9 million for Q2 2026, an improvement from a $6.7 million loss in Q2 2025, with diluted loss per share at $(0.04). The company had no product revenue and relied on grant funding, which totaled …

Cognizant (CTSH) Q2 2026 Earnings Call Transcript

Kaplan Fox & Kilsheimer LLP Alerts Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Investors to the Lead Plaintiff Deadline on September 21, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) for investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the demand for optical wavelengths, leading to …

If You Invested $100 In Cogent Biosciences Stock 5 Years Ago, You Would Have This Much Today

Cogent Biosciences (NASDAQ: COGT) has significantly outperformed the market over the past five years, with an annualized return of 40.76%. An initial investment of $100 in COGT stock five years ago would now be worth $584.69. This article highlights the power of compounded returns …

CCOI Stockholders with Large Losses Should Contact Robbins LLP for Information About Recovering Their Losses Against Cogent Communications Holdings, Inc.

Robbins LLP, a shareholder rights law firm, has filed a securities class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased stock between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent made false or …

Loss-Making Cogent Biosciences, Inc. (NASDAQ:COGT) Expected To Breakeven In The Medium-Term

This article analyzes Cogent Biosciences, Inc.'s financial performance and future prospects, focusing on its path to breakeven. Analysts project the company to reach profitability within two years, with significant revenue growth expected in the coming years. The piece also delves into the risks and …

Cogent Communications (NASDAQ:CCOI) Given New $14.00 Price Target at Wells Fargo & Company

CCOI Investors Have Opportunity to Lead Cogent Communications Holdings, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cogent Communications Holdings, Inc. (“Cogent” or “the Company”) (NASDAQ: CCOI) for violations of §§10(b) and 20(a) …

ROSEN, A LONGSTANDING LAW FIRM, Encourages Cogent Communications Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CCOI

Rosen Law Firm is reminding investors of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) who purchased common stock between February 29, 2024, and May 1, 2026, about the September 21, 2026, deadline to seek lead plaintiff status in a securities class action lawsuit. The lawsuit …

Cogent Communications (NASDAQ:CCOI) Reaches New 12-Month Low - Time to Sell?

Cognex Q2 Earnings Call Centers on AI and Data Center Growth

Cognex's Q2 2026 earnings call highlighted growth driven by an improving industrial cycle and a strategic focus on AI-enabled machine vision, new customers, and emerging markets like the data center supply chain. The company emphasized its AI platforms, customer expansion, and efforts to maintain …

Cogent Incurs Narrower-Than-Expected Q2 Loss Despite Lower Revenues

Cogent Communications Holdings, Inc. (CCOI) reported a mixed second quarter, with a narrower-than-expected net loss of 80 cents per share, beating the Zacks Consensus Estimate of a $1.12 loss. However, revenues of $235.6 million missed expectations due to declines in off-net revenues and the …

Cogent Communications (NASDAQ:CCOI) Given New $15.00 Price Target at KeyCorp

Cognition Therapeutics Q2 Net Loss Narrows; Plans Phase 3 DLB Study Of Zervimesine In Mid 2027

(RTTNews) - Cognition Therapeutics, Inc. (CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, reported second quarter results reflecting a narrowed net loss and provided a business update. The company's lead candidate, Zervimesine (CT1812), is an investigational once-daily oral therapy being evaluated …

Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update

Cognition Therapeutics reported its financial results for the second quarter of 2026, highlighting progress in its clinical and corporate priorities, particularly for its lead candidate zervimesine. The company held discussions with the FDA for a Phase 3 trial in dementia with Lewy bodies (DLB) …

Cogent Communications Holdings, Inc. Stock 12‑Month Price Target Cut to $21.73, Implies 69% Upside

The average 12-month price target for Cogent Communications Holdings, Inc. (CCOI) stock has been lowered from $22.64 to $21.73 by 11 analysts, with a range of $14 to $40 per share. Despite this cut, the new target implies a significant 69% potential upside from …

Cognex (CGNX) Stock Drops Despite Record Margins And Raised Outlook

Cognex Corp (CGNX) (Q2 2026) Earnings Call Highlights: Record Revenue and Margin Expansion Fuel ...

Cognex Corp (CGNX) reported record quarterly revenue in Q2 2026, up 17% year-over-year, alongside significant margin expansion, with adjusted EBITDA margin increasing 1,150 basis points to 32.2%. The company saw strong demand in logistics, electronics, and semiconductor markets, driven by the growing data center …

Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Declares $0.02 Quarterly Dividend

Cogent Communications Holdings, Inc. (NASDAQ:CCOI) has declared a quarterly dividend of $0.02 per share, payable on September 4th to shareholders of record on August 21st. This represents an annualized dividend of $0.08 and a 0.7% yield, though the company's negative earnings mean the dividend …

Cogeco Communications Announces $200 Million Reopening of Senior Secured Notes due 2033

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S./ MONTRÉAL, Aug. 6, 2026 /CNW/ -- Cogeco Communications Inc. (TSX: CCA) ("Cogeco Communications" or the "Corporation") announced today that it has priced an offering of an additional $200 million aggregate principal …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cogent Communications Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - CCOI

Pomerantz LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who incurred losses. The lawsuit alleges securities fraud or unlawful business practices, stemming from a series of financial disclosures that led to significant drops in …

Cogent targets 6%-8% multiyear revenue growth while continuing Sprint data center monetization and 2027 notes refinancing

Earnings Call Insights: Cogent Communications (CCOI) Q2 2026 MANAGEMENT VIEW * “We have made significant progress in several areas: our data center monetization, our net leverage reduction, our cost reduction, and completion of various integration projects,” said Founder, Chairman, CEO & President David Schaeffer. …

Cognition plans mid-2027 dementia trial; patent could extend to 2045

Cognition Therapeutics (NASDAQ: CGTX) reported a Q2 2026 net loss of $3.9 million, a significant reduction from $6.7 million in Q2 2025. The company announced its intention to initiate a Phase 3 trial for zervimesine in dementia with Lewy bodies (DLB) psychosis in mid-2027 …

Cogent Communications (NASDAQ:CCOI) Trading Down 11.6% - Should You Sell?

Cogent Communications (NASDAQ:CCOI) shares dropped 11.6% after reporting mixed Q2 results. While GAAP EPS beat expectations due to a data-center sale, core service revenue declined, and adjusted EPS showed a loss. The company faces ongoing legal pressure from a securities class action and has …

CCOI Deadline Alert: SueWallSt Reminds COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI) Investors of Securities Class Action Deadline on September 21, 2026

SueWallSt is reminding investors of Cogent Communications Holdings, Inc. (CCOI) about a securities class action lawsuit with a lead plaintiff deadline of September 21, 2026. The lawsuit alleges that Cogent made misleading statements regarding its wavelength-driven growth, dividend strength, and the success of its …

Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates

Cognition Therapeutics (CGTX) reported a Q2 loss of $0.04 per share, surpassing the Zacks Consensus Estimate of a $0.06 loss, marking a 33.33% surprise. However, the company missed revenue estimates, posting -$1 million against an expectation of zero revenue, and its shares have dropped …

Cogent Communications Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CCOI) 2026-08-06

Cogent Communications Holdings, Inc. published its Q2 2026 earnings call presentation. The company reported an EPS of -$0.45, beating estimates by $0.50, and revenue of $235.56M, missing estimates by $4.23M with a 4.34% year-over-year decrease. The presentation was released in conjunction with their earnings …

Earnings call transcript: Cognex posts record Q2 2026 revenue, shares slip

Cognex Corp. reported record second-quarter 2026 revenue of $291 million, up 17% year-over-year, and adjusted earnings per share of $0.45, surpassing analyst estimates. Despite strong financial performance and an optimistic full-year outlook, the company's stock experienced a slight slip in after-hours trading, likely due …

Cogent (CCOI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Cogent Communications (CCOI) reported revenue of $235.56 million, down 4.3% over the same period last year. EPS came in at -$0.80, compared to -$1.21 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Alpha Cognition Inc. (ACOG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results …

Is Cogent Communications (CCOI) a Value Play After Q2 Earnings M

COGNEX CORP 2026: Revenue $291.26M, EPS $0.43— 10-Q Summary

COGNEX CORP (CGNX) reported strong financial results for the quarter ended 2026, with revenue reaching $291.26 million and diluted EPS of $0.43, significantly up from the prior year. The growth was driven by broad-based demand, favorable foreign exchange, and strong geographic performance in Greater …

Cogent (NASDAQ:CCOI) Misses Q2 CY2026 Sales Expectations

Cogent (NASDAQ:CCOI) Misses Q2 CY2026 Sales Expectations Internet service provider Cogent Communications (NASDAQ:CCOI) fell short of the market's revenue expectations in Q2 CY2026, with sales falling 4.3% year on year to $235.6 million. Its GAAP profit of $1.38 per share was significantly above analysts' …